21149 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases
#602Methods of promoting immunity to an infectious agent by administering CD40 agonists and alpha-galactosyl ceramide
#603Methods for the treatment or prevention of systemic sclerosis
#604Diagnosing and treating IGA nephropathy
#605Therapy-enhancing glucan
#606Anti-glucagon receptor antibodies and pharmaceutical compositions thereof
#607METHOD AND COMPOSITION FOR ALTERING A B CELL MEDIATED PATHOLOGY
#608Compositions for the treatment of rheumatoid arthritis and methods of using same
#609COMBINATION THERAPIES FOR TREATING TYPE 1 DIABETES
#610Antigen binding proteins
#611Method of treating stress hyperglycemia with human antibodies to the glucagon receptor
#612Specific binding proteins and uses thereof
#613Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#614Combination therapies employing GITR binding molecules
#615Sequential antibody therapy
#616Anti-PDGFR-beta antibodies and uses thereof
#617METHOD OF ADMINISTERING AN ANTIBODY
#618Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
#619Sustained release formulations for delivery of proteins to the eye and methods of preparing same
#620Humanised anti-CD52 antibodies
#621Antibodies to insulin-like growth factor I receptor
#622Modulation of NKG2D for prolonging survival of a hematopoietic graft
#623Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#624Anti-CD40 antibodies and methods of administering thereof
#625CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF
#626Methods for treating or preventing asthma by administering an IL-4R antagonist
#627Anti-CD19 antibodies and uses in B cell disorders
#628Therapeutic method and medicament for HTLV-1 associated myelopathy
#629Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
#630Monoclonal antibody having immunosuppressive activity or antigen binding fragment thereof
#631Nucleic acids encoding human glucagon receptor antibodies
#632Methods of Using Anti-Thymocyte Globulin and Related Agents
#633Anti-TrkA antibodies, derivatives and uses thereof
#634Therapeutic anti-TIRC7 antibodies for use in immune related and other diseases
#635Compositions and methods including a recombinant human MAB that promotes CNS remyelination
#636HIGH-CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS
#637COMBINATION THERAPY INCLUDING TUMOR ASSOCIATED ANTIGEN BINDING ANTIBODIES
#638Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
#639Methods for the treatment or prevention of systemic sclerosis
#640HUMAN ANTIBODIES AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASE
#641Preparation of isolated agonist anti-EDAR monoclonal antibodies
#642Amino acyl tRNA synthetases for modulating inflammation
#643Antibodies inhibiting c-Met dimerization, and uses thereof
#644Specific binding proteins and uses thereof
#645Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor
#646Methods for reducing viral load in HIV-1 infected patients
#647Resettable ball seat
#648Therapeutic methods using anti-CD200 antibodies
#649Therapy-enhancing glucan
#650Immunotherapy using redirected allogeneic cells
#651Methods and compositions to regulate hepcidin expression
#652Antibody molecules to oncogenic isoforms of fibroblast growth factor receptor-2 and uses thereof
#653Humanized antibodies to iNKT
#654Immunotherapy comprising TLR9 ligand and CD40 ligand
#655Aminoacyl tRNA synthetases for modulating inflammation
#656TREATMENT OF PULMONARY EDEMA
#657MODULATION OF SRPX2-MEDIATED ANGIOGENESIS
#658ANTI-CD19 ANTIBODIES AND USES IN B CELL DISORDERS
#659LIVER TARGETING MOLECULES
#660Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody
#661TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE
#662COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES
#663Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#664TREATMENT WITH ANTI-VEGF ANTIBODIES
#665METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#666METHOD FOR GENERATING AND SELECTING ANTIBODIES AGAINST TARGET PROTEIN
#667Modulation of yeast-based immunotherapy products and responses
#668Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
#669METHOD OF TREATING HEMOLYTIC DISEASE
#670Polynucleotide encoding anti-CD14 antibody fusion protein
#671CD37-binding molecules and immunoconjugates thereof
#672Viral chemokine-antigen fusion proteins
#673EXTENDED TREATMENT OF MULTIPLE SCLEROSIS
#674DIAGNOSING AND TREATING IGA NEPHROPATHY
#675Hemojuvelin fusion proteins
#676Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
#677COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#678Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#679COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#680COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#681DOSAGE REGIMEN FOR ADMINISTERING AN EpCAMxCD3 BISPECIFIC ANTIBODY
#682METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES USING IMMUNOMODULATORY AGENTS
#683Preparation of isolated agonist anti-EDAR monoclonal antibodies
#684STIM2-MEDIATED CAPACITIVE CALCIUM ENTRY
#685Specific binding proteins and uses thereof
#686Methods of treating inflammatory and autoimmune diseases with natalizumab
#687Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate
#688Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate
#689Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
#690Methods using immunomodulatory compounds for treatment of certain leukemias
#691COMBINATION OF ANTI-CTLA4 ANTIBODY WITH DASATINIB FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#692USE OF HIGH-DOSE OXAZAPHOSPHORINE DRUGS IN COMBINATION WITH MONOCLONAL ANTIBODIES FOR TREATING IMMUNE DISORDERS
#693Human antibodies to the human glucagon receptor and methods of use thereof
#694Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
#695Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
#696Method and composition for altering a B cell mediated pathology
#697B-lymphocyte targeting agents for use in a method for the treatment of a disease
#698Methods for treating bone loss with antibodies to OPGL
#699Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism
#700MODULATION OF NKG2D
#701ANTIGEN-BINDING PROTEINS
#702Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#703Method of Administering an Antibody
#704Methods for the treatment or prevention of systemic sclerosis
#705Compositions and methods for treating cancer
#706Molecules that bind CD180, compositions and methods of use
#707Methods for treating inflammatory bowel disease
#708Antibodies to insulin-like growth factor I receptor
#709ANTI-CTLA-4 AND CPG-MOTIF-CONTAINING SYNTHETIC OLIGODEOXYNUCLEOTIDE COMBINATION THERAPY FOR CANCER TREATMENT
#710SPECIFIC BINDING PROTEINS AND USES THEREOF
#711Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
#712In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles
#713Anti-KIR combination treatments and methods
#714IMMUNOSTIMULATORY COMBINATIONS
#715METHODS OF PREVENTING OR TREATING INFLAMMATORY OR AUTOIMMUNE DISORDERS BY ADMINISTERING CD2 ANTAGONISTS IN COMBINATION WITH OTHER PROPHYLACTIC OR THERAPEUTIC AGENTS
#716METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES
#717Antibodies against vascular endothelial growth factor receptor-1
#718Antibodies against CSF-1R
#719IMMUNOSUPPRESSIVE COMBINATION AND ITS USE IN THE TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION
#720Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#721COMPOSITION FOR TREATING DISEASE
#722Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist
#723Therapy-enhancing glucan
#724CD20 antibodies and uses thereof
#725CD20 antibodies and uses thereof
#726Methods and Compositions for Treating Conditions of the Eye
#727COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha
#728CD37 immunotherapeutics and uses thereof
#729ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS
#730TREATMENT OF PULMONARY EDEMA
#731TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
#732TREATMENT WITH ANTI-VEGF ANTIBODIES
#733Therapeutic uses of inhibitors of RTP801
#734Viral chemokine-antigen fusion proteins
#735Methods for Enhancing the Efficacy of Vascular Disrupting Agents
#736Anti-CD19 antibodies and uses in B cell disorders
#737Compositions and methods for preventing or treating a viral infection
#738Canine anti-CD20 antibodies
#739METHODS OF ADMINISTERING/DOSING CD2 ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISORDERS OR INFLAMMATORY DISEASES
#740METHOD OF TREATING HEMOLYTIC DISEASE
#741Apo-2L receptor agonist and CPT-11 synergism
#742PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
#743Rationally-designed anti-αβν6 integrin antibody MFEVP1 and variants thereof, method of making such antibody and the use thereof in treating and diagnosis of disease
#744MODULATION OF SRPX2-MEDIATED ANGIOGENESIS
#745METHODS OF MODULATING IMMUNE RESPONSES BY MODULATING TIM-1, TIM-2 AND TIM-4 FUNCTION
#746METHODS OF TREATING HEMATOLOGIC CANCERS USING PNP INHIBITORS SUCH AS FORODESINE IN COMBINATION WITH ALKYLATING AGENTS OR ANTI-CD20 AGENTS
#747INHIBITION OF PLATELET AGGREGATION
#748Methods of treating eye diseases in diabetic patients
#749COMBINATION TREATMENT FOR NON-HEMATOLOGIC MALIGNANCIES
#750TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
#751Combination Therapy to Treat Persistent Viral Infections
#752Compositions and methods of tolerizing a primate to an antigen
#753Ex vivo uses of immunostimulatory combinations
#754Combinations of antibodies selective for DR5 and other therapeutic agents
#755TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)
#756Treatment of multiple sclerosis with laquinimod
#757T CELL DEPLETING COMPOSITIONS USEFUL FOR TREATING CANCER
#758Combination therapies for treating type 1 diabetes
#759Method of treating rheumatoid arthritis with an IL-6R antibody
#760MEANS AND METHODS FOR ENHANCING DIFFERENTIATION OF HAEMATOPOIETIC PROGENITOR CELLS
#761Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
#762Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
#763NOVEL BONE MASS INCREASING AGENT
#764ANTI-IGF-I RECEPTOR ANTIBODIES
#765Antibodies to insulin-like growth factor I receptor
#766Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
#767Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide
#768INDUCTION OF IMMUNE TOLERANCE
#769Method For Generating and Selecting Antibodies Against Target Protein
#770TREATMENT WITH ANTI-VEGF ANTIBODIES
#771Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
#772THERAPY-ENHANCING GLUCAN
#773FcgammaRIIB Fusion Proteins and Compositions Thereof
#774Methods of treating inflammatory and autoimmune diseases with natalizumab
#775ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF
#776METHODS OF TREATING CARDIOVASCULAR DISORDERS
#777Modulation of NKG2D
#778Methods of Treating Autoimmune Diseases
#779Combination of an anti-EP-CAM antibody with a chemotherapeutic agent
#780Fully human antibodies directed against the human insulin-like growth factor-1 receptor
#781Methods for the treatment of infections and tumors
#782TOLERANCE INDUCTION AND MAINTENANCE IN HEMATOPOIETIC STEM CELL ALLOGRAFTS
#783METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTRATION OF ALPHA-FETOPROTEIN IN COMBINATION WITH AN INTEGRIN ANTAGONIST
#784COMBINATION THERAPY FOR B CELL DISORDERS
#785COMBINATION AND TREATMENT FOR MULTIPLE SCLEROSIS
#786Methods for Treatment of HIV and Other Infections Using A T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#787Antibodies inhibiting c-Met dimerization and uses thereof
#788COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER
#789Combination of anti-CTLA4 antibody with dasatinib for the treatment of proliferative diseases
#790Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation
#791Treatment method using EGFR antibodies and SRC inhibitors and related formulations
#792Methods for human allografting
#793METHOD OF TREATING HEMOLYTIC DISEASE
#794SPECIFIC BINDING PROTEINS AND USES THEREOF
#795Immuno-Stimulant Combination for Prophylaxis and Treatment of Hepatitis C
#796Methods of Using Anti-Thymocyte Globulin and Related Agents
#797Antibodies against vascular endothelial growth factor receptor-1
#798Antibody formulations
#799Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs
#800BLOCKING IMMUNE RESPONSE TO A GRAFT
#801Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts
#802Methods of using death receptor ligands and cd20 antibodies
#803Gene constructs coding for CD40-binding activating antibodies
#804Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies
#805NOVEL MEMORY CTL INDUCTION POTENTIATOR
#806CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
#807CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
#808Use of CD25 binding molecules in steroid-resistant patients
#809Polynucleotides encoding heavy and light chains of antibodies to OPGL
#810Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
#811RESPONSES TO IMMUNIZATIONS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH A CD20 ANTIBODY
#812Method of treating drug-resistant cancer
#813TREATMENT WITH ANTI-VEGF ANTIBODIES
#814METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE
#815Specific binding proteins and uses thereof
#816Method of treating cd30 positive lymphomas
#817Combination Of Anti-Madcam Antibody And Antifibrotic Caspase Inhibitor To Treat Liver Fibrosis
#818Anti-Kir Combination Treatments and Methods
#819Treatment with anti-VEGF Antibodies
#820Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents
#821Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexate
#822Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
#823APO-2L receptor agonist and CPT-11 synergism
#824THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS
#825SPECIFIC REMOVAL OF ACTIVATED IMMUNE CELLS
#826Methods for conditioning a subject for hematopoietic cell transplantation
#827Materials and Methods for Reversing Type-1 Diabetes
#828ANTI-IGF-I RECEPTOR ANTIBODY
#829Anti-IGF-I receptor antibody
#830Composition for treating cancer adapted for intra-tumoral administration and uses thereof
#831Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease
#832Specific binding proteins and uses thereof
#833COMBINED TREATMENT WITH AN EGFR KINASE INHIBITOR AND AN INHIBITOR OF C-KIT
#834Combination therapies employing GITR binding molecules
#835Anti-CD20 antibodies and methods of use
#836TLR9 agonist and CD40 agonist immunostimulatory combinations
#837Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer Treatment
#838Methods and compositions using CD3 agonists
#839Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
#840Methods for Treating Cancer
#841Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer
#842Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
#843Humanized anti-CD79b antibodies and immunoconjugates and methods of use
#844Treatment And Prophylaxis With 4-1BB-Binding Agents
#845Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents
#846Treatment with Anti-VEGF Antibodies
#847Novel Combinational Use of Sulfonamide Compound
#848PARATHYROID AND THYMUS TRANSPLANTATION IN DIGEORGE SYNDROME SUBJECTS
#849Apo-2L receptor agonist and CPT-11 synergism
#850COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha
#851Treatment of hematologic disorders
#852AGENTS AND METHODS FOR INHIBITION OF AIRWAY HYPERRESPONSIVENESS
#853Combinations of antibodies selective for DR5 and other therapeutic agents
#854Extended Treatment of Multiple Sclerosis
#855TREATMENT WITH ANTI-VEGF ANTIBODIES
#856TREATMENT WITH ANTI-VEGF ANTIBODIES
#857Synergistic compositions for treating HIV-1
#858TREATMENT WITH ANTI-VEGF ANTIBODIES
#859TREATMENT WITH ANTI-VEGF ANTIBODIES
#860Anti-CD14 antibody fusion protein
#861Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy
#862Treatment With Anti-VEGF Antibodies
#863TREATMENT WITH ANTI-VEGF ANTIBODIES
#864Methods and compositions to regulate iron metabolism
#865Treatment of Severe Multiple Sclerosis
#866Anti-T Cell and Autoantigen Treatment of Autoimmune Disease
#867TREATMENT WITH ANTI-VEGF ANTIBODIES
#868TREATMENT WITH ANTI-VEGF ANTIBODIES
#869TREATMENT WITH ANTI-VEGF ANTIBODIES
#870Methods for reducing viral load in HIV-1-infected patients
#871Treatment of Viral Infections
#872Compositions and methods for preventing or treating a viral infection
#873IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#874IMMUNOREGULATORY ANTIBODIES AND USES THEREOF
#875Combined Use Of A Modulator Of CD3 And A GLP-1 Compound
#876USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#877USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#878USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#879Antilymphocyte Antibody Induction
#880IMMUNOSUPPRESSIVE COMBINATION AND ITS USE IN THE TREATMENT OR PROPHYLAXIS OF INSULIN-PRODUCING CELL GRAFT REJECTION
#881Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
#882THERAPY-ENHANCING GLUCAN
#883TREATING AND EVALUATING INFLAMMATORY DISORDERS
#884Single-chain Antibodies Against Human Insulin-Like Growth Factor I Receptor: Expression, Purification, and Effect on Tumor Growth
#885Methods for human allografting
#886USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#887Use Of Cd25 Antibodies In Immunotherapy
#888ANTIBODIES FOR CANCER THERAPY AND DIAGNOSIS
#889TREATMENT WITH ANTI-VEGF ANTIBODIES
#890TREATMENT WITH ANTI-VEGF ANTIBODIES
#891Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
#892Compositions and methods of tolerizing a primate to an antigen
#893Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#894Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis
#895ANTI-CD20 ANTIBODIES AND METHODS OF USE
#896Method for Augmenting B Cell Depletion
#897mCRP antagonists and their uses
#898Induction And Maintenance Of Tolerance To Composite Tissue Allografts
#899Methods of using death receptor ligands and CD20 antibodies
#900Method for the treatment of multiple sclerosis